134 related articles for article (PubMed ID: 3440448)
1. Hyperammonemia related to carnitine metabolism with particular emphasis on ornithine transcarbamylase deficiency.
Matsuda I; Ohtani Y; Ohyanagi K; Yamamoto S
Enzyme; 1987; 38(1-4):251-5. PubMed ID: 3440448
[TBL] [Abstract][Full Text] [Related]
2. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.
Ratnakumari L; Qureshi IA; Butterworth RF
Metabolism; 1993 Aug; 42(8):1039-46. PubMed ID: 8102193
[TBL] [Abstract][Full Text] [Related]
3. Neonatal onset of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome with favorable outcome.
Zammarchi E; Ciani F; Pasquini E; Buonocore G; Shih VE; Donati MA
J Pediatr; 1997 Sep; 131(3):440-3. PubMed ID: 9329423
[TBL] [Abstract][Full Text] [Related]
4. Alteration of urinary carnitine profile induced by benzoate administration.
Sakuma T
Arch Dis Child; 1991 Jul; 66(7):873-5. PubMed ID: 1863104
[TBL] [Abstract][Full Text] [Related]
5. Carnitine deficiency associated with ornithine transcarbamylase deficiency.
Mayatepek E; Kurczynski TW; Hoppel CL; Gunning WT
Pediatr Neurol; 1991; 7(3):196-9. PubMed ID: 1908679
[TBL] [Abstract][Full Text] [Related]
6. Chronic benzoate therapy in a boy with partial ornithine transcarbamylase deficiency.
Letarte J; Qureshi IA; Ouellet R; Godard M
J Pediatr; 1985 May; 106(5):794-7. PubMed ID: 3998920
[No Abstract] [Full Text] [Related]
7. A case of carbamylphosphate synthetase-I deficiency associated with secondary carnitine deficiency--L-carnitine treatment of CPS-I deficiency.
Mori T; Tsuchiyama A; Nagai K; Nagao M; Oyanagi K; Tsugawa S
Eur J Pediatr; 1990 Jan; 149(4):272-4. PubMed ID: 2303075
[TBL] [Abstract][Full Text] [Related]
8. Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency.
Ohtani Y; Ohyanagi K; Yamamoto S; Matsuda I
J Pediatr; 1988 Mar; 112(3):409-14. PubMed ID: 3346778
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of girls with ornithine transcarbamylase deficiency.
Maestri NE; Brusilow SW; Clissold DB; Bassett SS
N Engl J Med; 1996 Sep; 335(12):855-9. PubMed ID: 8778603
[TBL] [Abstract][Full Text] [Related]
10. Partial ornithine transcarbamylase deficiency associated with recurrent hyperammonemia, lethargy and depressed sensorium.
Oizumi J; Ng WG; Koch R; Shaw KN; Sweetman L; Velazquez A; Donnell GN
Clin Genet; 1984 Jun; 25(6):538-42. PubMed ID: 6733950
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term administration of sodium benzoate to a patient with partial ornithine carbamoyl transferase deficiency.
Takeda E; Kuroda Y; Toshima K; Watanabe T; Naito E; Miyao M
Clin Pediatr (Phila); 1983 Mar; 22(3):206-8. PubMed ID: 6825366
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous animal models of ornithine transcarbamylase deficiency: studies on serum and urinary nitrogenous metabolites.
Qureshi IA; Letarte J; Ouellet R
Adv Exp Med Biol; 1982; 153():173-83. PubMed ID: 7164896
[No Abstract] [Full Text] [Related]
13. Absence of acidosis in the initial presentation of propionic acidaemia.
Walter JH; Wraith JE; Cleary MA
Arch Dis Child Fetal Neonatal Ed; 1995 May; 72(3):F197-9. PubMed ID: 7796239
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of severe OTC deficiency.
Brubakk AM; Teijema LL; Blom W; Berger R
J Pediatr; 1982 Jun; 100(6):929-31. PubMed ID: 7086593
[No Abstract] [Full Text] [Related]
15. Treatment of urea cycle disorders.
Batshaw ML; Monahan PS
Enzyme; 1987; 38(1-4):242-50. PubMed ID: 3326732
[TBL] [Abstract][Full Text] [Related]
16. Chronic sodium benzoate therapy in children with inborn errors of urea synthesis: effect on carnitine metabolism and ammonia nitrogen removal.
Feoli-Fonseca JC; Lambert M; Mitchell G; Melançon SB; Dallaire L; Millington DS; Qureshi IA
Biochem Mol Med; 1996 Feb; 57(1):31-6. PubMed ID: 8812724
[TBL] [Abstract][Full Text] [Related]
17. [Abrupt onset and rapid deterioration in the course of congenital ornithine transcarbamylase deficiency: a case report].
Fukuizumi H; Kudo J; Shimamura R; Fujimoto K; Ishibashi H; Niho Y; Taniyama T; Kumashiro T
Fukuoka Igaku Zasshi; 1990 Jul; 81(7):247-53. PubMed ID: 2210591
[TBL] [Abstract][Full Text] [Related]
18. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.
Batshaw ML; Roan Y; Jung AL; Rosenberg LA; Brusilow SW
N Engl J Med; 1980 Feb; 302(9):482-5. PubMed ID: 7351973
[TBL] [Abstract][Full Text] [Related]
19. The study of organic acids metabolism in a patient with ornithine transcarbamylase (OTC) deficiency.
Kodama H; Nose O; Okada S; Yabuuchi H
Adv Exp Med Biol; 1982; 153():341-50. PubMed ID: 7164909
[No Abstract] [Full Text] [Related]
20. Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy.
Pridmore CL; Clarke JT; Blaser S
J Child Neurol; 1995 Sep; 10(5):369-74. PubMed ID: 7499756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
